Aptiv Delivering Production-Ready Edge AI with Long-Term Support with NVIDIA SeqLL Announces Publication of a New Single-Cell Epitranscriptomic Method Powered by SeqLL’s tSMS® Platform
Method developed by leading researchers at the Bernstein Laboratory and SeqLL Inc. Funding for the…
New Expanded, Updated Edition of OnePoint Patient Care Clinical Symptom Guide Now Available
OPPC OPPC TEMPE, Ariz., Sept. 23, 2021 (GLOBE NEWSWIRE) — OnePoint Patient Care has published…
Medolife Rx Launches Ad Campaign With Tony Hawk, Sees Immediate Positive Results
BURBANK, CA, Sept. 23, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a global integrated…
Alpha Cognition Announces Pricing of Public Offering
NOT FOR DISSEMINATION IN THE UNITED STATESOR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Sept….
Todos Medical Launches Tollovid Daily™ via Subscription at MyTollovid.com
Consumers can subscribe for an auto-shipped supply of Tollovid Daily™ 3CL protease inhibitor for immune…
SCYNEXIS to Present Data on Oral Ibrexafungerp at IDWeek 2021 from Interim Analyses of Phase 3 FURI Clinical Trial Showing Therapeutic Response Rates in Patients with Mucocutaneous and Invasive Fungal Infections
Analysis of subpopulations from a total of 74 patients evaluated to date from FURI includes…
Surrozen Announces Appointment of Liz Nguyen as Vice President and Head of Human Resources
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — Surrozen Inc. (Nasdaq: SRZN), a…
Scopus BioPharma to Present at the Benzinga Healthcare Small Cap Conference
Scopus to present on launch of Duet Therapeutics, its wholly-owned subsidiary focused on immuno-oncology NEW YORK,…
Ayala Pharmaceuticals Announces Publication Highlighting Clinical Activity of its Gamma Secretase Inhibitor AL101 in Desmoid Tumors
REHOVOT, Israel and WILMINGTON, Del., Sept. 23, 2021 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (NASDAQ:…
Celldex Announces Upcoming Presentation of CDX-0159 Phase 1b Results in Inducible Urticaria at the 2021 European Academy of Dermatology and Venereology (EADV) 30th Congress
HAMPTON, N.J., Sept. 23, 2021 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that…
Novan Reports Safety Data from B-SIMPLE4 Pivotal Phase 3 Study of SB206
– SB206 demonstrates continued favorable safety profile consistent with previous studies and meets Company’s expectations…
Gain Therapeutics to Present at the Cantor Virtual Global Healthcare Conference
Conference Dates: September 27th-30th BETHESDA, Md., Sept. 23, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc….
Soleno Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
REDWOOD CITY, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
Frontier Medicines to Present at the Cantor Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 23, 2021 (GLOBE NEWSWIRE) — Frontier Medicines Corporation, a precision…
POINT Biopharma Announces Initiation of Randomization for its Phase 3 SPLASH study Evaluating PNT2002 for mCRPC
25 patient dosimetry and safety run-in met all pre-specified safety and efficacy criteria Initiated patient…
BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com
BriaCell Therapeutics CEO Interview BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with…
Nanox to Present at the Cantor Fitzgerald Global Healthcare Conference
NEVE ILAN, Israel, Sept. 23, 2021 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox”…
TFF Pharmaceuticals Announces Promising Topline Results from Phase 1 Clinical Trial of Inhaled Tacrolimus Powder and Progression Toward Phase 2 in Lung Transplantation
Inhaled Tacrolimus Shows Dose-Dependent PK that Achieves Desired Therapeutic Plasma Concentrations and Promising Safety Profile…
TG Therapeutics Announces Publication of Results from an Integrated Safety Analysis of UKONIQ® (umbralisib) in Blood Advances
NEW YORK, Sept. 23, 2021 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX) today announced…
TG Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference
Fireside chat scheduled for 10:40 AM ET on Monday, September 27, 2021 NEW YORK, Sept….